Oxypurinol
SIGMA/O6881 - ≥98% (HPLC)
CAS Number: 2465-59-0
Empirical Formula (Hill Notation): C5H4N4O2
Molecular Weight: 152.11
EC Number: 219-570-9
MDL Number: MFCD00056934
Linear Formula: C5H4N4O2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| form | powder |
| InChI | 1S/C5H4N4O2/c10-4-2-1-6-9 |
| InChI key | HXNFUBHNUDHIGC-UHFFFAOYSA |
| Quality Level | 200 ![]() |
| SMILES string | O=C1NC(=O)c2cn[nH]c2N1 |
| solubility | 1 M NaOH: 49.00-51.00 mg/mL, clear to slightly hazy, colorless to yellow (heated NaOH) |
| Application: | Oxypurinol has been used as a xanthine oxidase inhibitor, to evaluate its effects on hepatocellular carcinoma cell proliferation. It has also been used as a xanthine inhibitor to elucidate its contribution in the induction of hpv16 late gene expression. |
| Application: | Oxypurinol, an allopurinol metabolite, is used as an inhibitor to study the specificity and kinetics of of xanthine oxidase(s). Oxypurinol is also used as an anti-inflammatory agent via inhibition of xanthine oxidase. |
| Biochem/physiol Actions: | An allopurinol metabolite. |
| Biochem/physiol Actions: | Oxypurinol has the ability to stimulate osteoblast differentiation and enhance the formation of bone. It is used to treat gout and hyperuricemia. Oxypurinol is considered as a strong antioxidant. It can prevent the actions of xanthine oxidase (XO) in osteoblasts. |
| Packaging: | 100, 500 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| UNSPSC | 41106305 |


